ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,934.00
-20.00 (-1.02%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -1.02% 1,934.00 1,925.00 1,926.00 1,956.00 1,919.00 1,955.00 145,039 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.25 4.34B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,954p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,722.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.34 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.25.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1701 to 1722 of 1875 messages
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
03/8/2022
14:10
Wonder if bears closing just in case figures might be half decent,
montyhedge
03/8/2022
13:34
Been creeping up slowly, always two steps forward, one back.
montyhedge
01/8/2022
15:47
Think that's a bit simplistic. Value always comes out in the end and was expecting Hikma to be @£32 at this stage. Oh well
robertball
01/8/2022
12:53
True, not one SELL by an analyst.
montyhedge
01/8/2022
12:13
Broker target prices are useless in my view. Typically follow the news rather than lead the news

The company is trading on only a 11x PE and the only other time in the last 20 years that its dropped sub 10x aside from recently was late 2008.

Unless analyst forecasts are badly wrong and this starts to shrink, the price IMO is likely far too low. Even if earnings were flat, you'd make say 7%+ based on the share buy back (assume market cap remains flat but fewer shares) plus the divi.

As always, you can never be certain and making investments is simply a process of placing a series of reasoned bets where you feel there is more upside potential than downside. Personally I believe the risk is assymetric here

adamb1978
01/8/2022
07:45
Make or break thurs i think. Under 10 GBP if numbers are off
scepticalinvestor
01/8/2022
07:21
That maybe rectified on Thursday. At the moment seems a crazy low valuation, all will be revealed 4th August.
montyhedge
30/7/2022
11:11
If we're going to keep regurgitating broker price forecasts, at least we could try to be objective about it.

Of 12 analysts, 10 quote "buy" and 2 quote "hold" at the moment.

The low, medium and high price targets are 1900p, 2367p and 2937p.

This is from IBKR.

It's rare to see a broker price target that is below the current price anyway.

mjneish
29/7/2022
10:34
Interims next Thursday 4th Aug, another dividend rise the same as it has been for last 15 years. If decent perhaps get on its way to Barclays target 2500p.
montyhedge
28/7/2022
20:27
Don’t you ever get bored of being wrong?
blue59
28/7/2022
09:41
It will end the day up, forward momentum to strong for bears, they are trying to get shareprice down.
montyhedge
28/7/2022
07:02
Always marked down...must still be a large holder dumping
scepticalinvestor
27/7/2022
10:24
Quietly moving up to Barclays 2500p target.https://www.directorstalkinterviews.com/hikma-pharmaceuticals-plc-40.4-potential-upside-indicated-by-barclays/4121069274
montyhedge
27/7/2022
07:20
‘Tuck away’ = sitting on a fat loss and going nowhere any time soon!
blue59
23/7/2022
15:47
It's a tuck away, like the article says.https://www.fool.co.uk/2022/07/18/i-think-these-are-the-best-shares-to-buy-now-for-the-next-decade-2/
montyhedge
21/7/2022
19:37
4th August, figures, I expect nothing spectacular, just steady has she's goes, dividend increase, just like it has been for the last 15 years.
montyhedge
21/7/2022
14:47
Slowly getting back over 2000p, figures will give Hikma a push.
montyhedge
18/7/2022
08:32
Two steps forward, one back, but on our way back to 2600p, figures due shortly should give more momentum to upside.
montyhedge
16/7/2022
06:06
Another for the filter button!
blue59
15/7/2022
17:37
Nah that your mum mate - gave me a blow for free
scepticalinvestor
14/7/2022
18:22
Skeppy Investor - Specialist in LOSING MONEY
buy2sell1
14/7/2022
14:24
Hikma I would have thought should be upgraded on weak sterling, perhaps after the figures in a couple of weeks time.
montyhedge
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older

Your Recent History

Delayed Upgrade Clock